Notice Number: NOT-HL-06-117
Release Date: February 1, 2006
National Heart, Lung, and Blood Institute (NHLBI), (http://www.nhlbi.nih.gov/)
The purpose of this Notice is to announce that NHLBI is withdrawing PA-04-028, "Competing Continuation Awards of SBIR Phase II Grants for Heart, Lung, Blood, and Sleep Disorders".
The funding opportunity (FOA) for NHLBI Phase II Competing Renewal Awards is now described in PHS 2006-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR[R43/R44]). The Program Announcement (PA) Number is PA-06-120 and the application submission dates are April 1, 2006 ; August 1, 2006 ; December 1, 2006 . Applications must be submitted electronically through Grants.gov (http://www.grants.gov) using the SF424 Research and Related (R&R) forms and the SF424 (R&R) SBIR/STTR Application Guide. Please see: https://grants.nih.gov/grants/guide/pa-files/PA-06-120.html for complete information about this FOA as well as the required one registration for institutions/organizations desiring to submit applications.
Direct questions about competing renewal applications to:
National Heart, Lung, and Blood Institute
6701 Rockledge Drive
Bethesda , MD 20892-7950
Phone: (301) 435-0079
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.